ASEAN shows a strong growth of health expenditure per capita leading by Singapore, Malaysia and Thailand. To find out more about other countries, check out our latest publication at http://bit.ly/1hmvwFq
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
IBC’s Indonesia Healthcare conference brings together healthcare leaders to discuss evolving policies, opportunities for private healthcare investment, partnerships, projects and initiatives.
Key Conference Themes:
Updates on Regulation and the Road Towards Universal Healthcare Coverage
Hospital Management & Cutting Edge Healthcare Delivery Standards
Digital Marketing and Telehealth Solutions
Healthcare Infrastructure Projects, Investments & Development
Generics & Access to Medicine
Public-Private Partnerships & Collaboration
Why You Must Attend This Year’s Event
Understand the proactive steps to take by hospitals, pharmaceutical and insurance companies for the new Universal Healthcare Coverage policy
Discover partnerships and investment opportunities in Indonesia
Hear different case studies from major hospitals, insurance and pharmaceutical companies
Meet and exchange business cards with your peers during the networking sessions
Learn how to deliver safe and quality healthcare from other Asian countries
Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted the absolute value following reassessment of the market size.
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
IBC’s Indonesia Healthcare conference brings together healthcare leaders to discuss evolving policies, opportunities for private healthcare investment, partnerships, projects and initiatives.
Key Conference Themes:
Updates on Regulation and the Road Towards Universal Healthcare Coverage
Hospital Management & Cutting Edge Healthcare Delivery Standards
Digital Marketing and Telehealth Solutions
Healthcare Infrastructure Projects, Investments & Development
Generics & Access to Medicine
Public-Private Partnerships & Collaboration
Why You Must Attend This Year’s Event
Understand the proactive steps to take by hospitals, pharmaceutical and insurance companies for the new Universal Healthcare Coverage policy
Discover partnerships and investment opportunities in Indonesia
Hear different case studies from major hospitals, insurance and pharmaceutical companies
Meet and exchange business cards with your peers during the networking sessions
Learn how to deliver safe and quality healthcare from other Asian countries
Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted the absolute value following reassessment of the market size.
The 2016 IMS APAC Insight Magazine provide insights to unveils new areas of play, new methodologies and new geographies that are poised to disrupt the healthcare landscape in this region.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
By Mr. Irish Pereira. With perspective on Healthcare Infrastructure, this report consists of an brief introduction of Indian healthcare sector, its market size, its growth drivers, healthcare infrastructure in India both public as well as private, Key Players in the Private Healthcare Segment,
1. What are the subgroups under hospitality industry?
2. Porters five force analysis
3. Growth drivers and strategies
4. Key trends
5. Major players
6. Risks
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the “Modi-care” –Health assurance for all.
The insights driving superior healthcare outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region, delivering fresh perspectives on how to navigate through the challenges and opportunities in Asia-Pacific pharmaceutical market.
In this paper, we seek to map the current state of affairs in the healthcare delivery space in the eastern states, explore recent trends in the sector, identify key areas requiring immediate action and offer recommendations that can ensure equitable access and quality healthcare to all.
The 2016 IMS APAC Insight Magazine provide insights to unveils new areas of play, new methodologies and new geographies that are poised to disrupt the healthcare landscape in this region.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
By Mr. Irish Pereira. With perspective on Healthcare Infrastructure, this report consists of an brief introduction of Indian healthcare sector, its market size, its growth drivers, healthcare infrastructure in India both public as well as private, Key Players in the Private Healthcare Segment,
1. What are the subgroups under hospitality industry?
2. Porters five force analysis
3. Growth drivers and strategies
4. Key trends
5. Major players
6. Risks
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the “Modi-care” –Health assurance for all.
The insights driving superior healthcare outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region, delivering fresh perspectives on how to navigate through the challenges and opportunities in Asia-Pacific pharmaceutical market.
In this paper, we seek to map the current state of affairs in the healthcare delivery space in the eastern states, explore recent trends in the sector, identify key areas requiring immediate action and offer recommendations that can ensure equitable access and quality healthcare to all.
This whitepaper provides an overview of medical device manufacturing in Asia. This paper includes key information on the global medical device market, global medical device market trends, Asia medical device market trends, Asia medical device manufacturing, setting up manufacturing facilities in Asia, and examples of manufacturing facilities in Asia. This whitepaper is intended for anyone interested in setting up or acquiring medical device manufacturing facilities in Asia.
For more information, contact us for a free 15 minute consultation at http://www.pacificbridgemedical.com/contact-us/.
Medical Devices & Diagnostics Asia - Balancing Risk & Reward WhitepaperSimranjit Singh
A whitepaper from Quintiles which looks at the growth potential of Asia pacific for medical devices and the approaches to navigate the complex regulatory pathways.
Indonesia Healthcare Landscape - An Overview, July 2014Praneet Mehrotra
A brief description of Indonesia's healthcare landscape and the challenges it faces. The country has no choice, but to attract greater investments (also importantly, foreign investments) in capacity creation.
To explore perceptions, Ipsos conducted a survey amongst a representative sample of more than 1000 Australians, which revealed that most people understand little about the range of technologies that fall under the AI banner and what they do know is informed by Hollywood — ‘the Terminator effect,’ if you like.
At a time when technology has the potential to change the way we travel, this new white paper reveals global consumer attitudes towards the prospect of fully automated cars.
Obesity is the third greatest social burden driven by human beings, after smoking and war, violence and terrorism. And while sugar consumption is far from the only cause of this, it is increasingly in the spotlight.
Foot on the Pedal - Opportunities Fuelled by a Booming ASEAN Automotive IndustryIpsos Business Consulting
ASEAN is one of the world’s fastest-growing markets, and has all the right elements for a robust automotive sector.
For more information, please email consulting.bc@ipsos.com
Indonesia, the Philippines, and Vietnam, which have led regional growth in healthcare over the past three years because of their on-going universal healthcare programmes, exhibit some of the sector’s strongest near-term potential within the region.
For more information, please contact consulting.bc@ipsos.com
Despite the relatively stable growing trend over the past few years, meat output has not managed to keep up with the consumption demand. Whilst domestic pork production is relatively sufficient for the domestic consumption demand, there is a significant shortage in the supply of beef and chicken.
For more information, please email vietnam.bc@ipsos.com
Indonesia’s DC construction market is expected to grow by 11.4% a year between now and 2020, supported by the expansion of colocation and managed hosting services provided by key DC suppliers to both large enterprises and SMEs.
For more information, please email indonesia.bc@ipsos.com
This presentation from the Ipsos automotive consultants in Korea covers:
- Domestic production sales
- Export to overseas markets
- Future technology such as connected cars, autopilot, eco-friendly cars etc
Email your questions and comments about the papers contents to korea.bc@ipsos.com
***NOTE: An English language translation of this presentation can be obtained by emailing korea.bc@ipsos.com, quoting "KAMA presentation"
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ASEAN - a Region with Potential for Healthcare Growth
1. healthcare.bc@ipsos.com
ASEAN, A REGION WITH POTENTIAL
FOR HEALTHCARE GROWTH
Source: Ipsos Business Consulting
Note: The calculation for ASEAN does not include Cambodia, Laos, Myanmar and Brunei Darussalam.
Singapore is not shown in the graph due to its extremly high healthcare spending per capita (i.e. 2015e is USD2,580).
Despite having low health expenditure per capita, ASEAN still possess a high potential for growth as there is a rising trend in assessing healthcare
services. For example, Indonesia aims to have more than 95% health coverage for the population by 2018.
ASEAN
Thailand
Malaysia
Indonesia
Vietnam
Philippines
2008
50
100
150
200
250
300
400
450
500
350
0
2009 2010 2011 2012 2013 2014 2015e 2018
US$ Health expenditure per capita